Conmed (CNMD) Other Non-Current Liabilities (2010 - 2026)

Conmed (CNMD) has 17 years of Other Non-Current Liabilities data on file, last reported at $61.9 million in Q2 2026.

• Quarterly Other Non-Current Liabilities fell 22.47% year-over-year to $61.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $61.9 million (down 22.47% YoY) and the FY2025 annual result came in at $63.9 million, down 26.01% from the prior year.
• Other Non-Current Liabilities eased to $61.9 million in Q2 2026, from $63.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $218.1 million in Q3 2022 to a low of $41.8 million in Q1 2022.
• A 5-year average of $110.5 million and a median of $100.9 million in 2024 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 373.8% — and 2024, when it plunged 41.41%.
• Tracing CNMD's Other Non-Current Liabilities over 5 years: stood at $203.7 million in 2022, then tumbled by 40.58% to $121.0 million in 2023, then declined by 28.7% to $86.3 million in 2024, then slipped by 26.01% to $63.9 million in 2025, then slipped by 3.08% to $61.9 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $61.9 million (Q2 2026), $63.0 million (Q1 2026), and $63.9 million (Q4 2025), per Business Quant data.